Sign up to save your podcasts
Or
Share When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
130 Listeners
Global News Podcast
7,681 Listeners
Neurology® Podcast
284 Listeners
NEJM This Week
320 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
492 Listeners
JAMA Neurology Author Interviews
14 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
320 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
362 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
77 Listeners